跳至主要内容
临床试验/NL-OMON39388
NL-OMON39388招募中不适用

A pilot study on the efficacy and pharmacokinetics of a switch from nevirapine with emtricitabine, tenofovir or lamivudine, tenofovir or lamivudine, zidovudine to rilpivirine with emtricitabine, tenofovir in virologically suppressed HIV-1 infected patients. - rilpivirine switch study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Able to take medication with a 500 kcal meal
  • Treated with NVP and FTC, TDF or 3TC, TDF or 3TC, ZDV for at least the last 9 months
  • No history of HIV virologic failure
  • The last 2 measured HIV-RNA levels in plasma were <50 copies/ml
  • >=6 months between the first and last plasma with <50 copies/ HIV RNA/ml

排除标准

  • Use of proton pump inhibitors.
  • Use of H2-antagonists
  • Use of other contraindicated concurrent medication

研究者

相似试验

A pilot study on the efficacy and pharmacokinetics... | 临床试验